<h4>Background</h4>Relapsed/refractory RUNX1::RUNX1T1-positive acute myeloid leukemia remains a therapeutic challenge due to high relapse rates post-allogeneic hematopoietic stem cell transplantation. The gene discussed is RUNX1T1; the disease is acute myeloid leukemia.